Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

324630 EHNA, Hydrochloride - CAS 51350-19-7 - Calbiochem

The racemic mixture of a cell-permeable adenine derivative that acts as a PDE II-selective phosphodiesterase inhibitor and adenosine deaminase.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: erythro-9-(2-Hydroxy-3-nonyl)adenine, HCl

Primary Target: PDE 2
324630
Purchase on Sigma-Aldrich

概述

Replacement Information

重要规格表

CAS #Empirical Formula
51350-19-7C₁₄H₂₃N₅O · HCl

Products

产品目录编号包装 数量 / 包装
324630-10MGCN 塑胶安瓿;塑胶针药瓶 10 mg
Description
OverviewThe racemic mixture of a cell-permeable adenine derivative that acts as a PDE II-selective phosphodiesterase inhibitor (IC50 = 0.8 and 2 µM against human and procine PDE II, respectively) and adenosine deaminase (Ki = 4 nM), while exhibiting little or much reduced potency toward PDE I/II/IV isozymes (IC50 >100 µM) of both human and porcine species. EHNA at 10 µM concentration is also reported to effectively and reversibly block the differentiation and maintain the pluripotency of hES (human embryonic stem) cell line SA121 in feeder-free cultures without exogenously added FGF for up to 30 passages in a manner independent of its known ADA and PDE inhibitory activities.
Catalogue Number324630
Brand Family Calbiochem®
Synonymserythro-9-(2-Hydroxy-3-nonyl)adenine, HCl
References
ReferencesBurton, P., et al. 2010. Biochem. J. in press.
Lorbar, M., et al. 1999. J. Mol. Cell. Cardiol. 31, 401.
Verde, I., et al. 1999. Br. J. Pharmacol. 127, 65.
Reynolds, A.J., et al. 1996. Brain Res. 798, 67.
Mery, P.F., et al. 1995. Mol. Pharmacol. 48, 121.
Podzuweit, T., et al. 1995. Cell. Signal. 7, 733.
Bessodes, M., et al. 1982. Biochem. Pharmacol. 31, 879.
Bouchard, P., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 1033.
Product Information
CAS number51350-19-7
ATP CompetitiveN
FormWhite solid
Hill FormulaC₁₄H₂₃N₅O · HCl
Chemical formulaC₁₄H₂₃N₅O · HCl
Hygroscopic Hygroscopic
ReversibleN
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetPDE 2
Primary Target IC<sub>50</sub>0.8 and 2 µM against human and procine PDE II, respectively
Primary Target K<sub>i</sub>4 nM against adenosine deaminase
Purity≥97% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage +2°C to +8°C
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
324630-10MGCN 04055977196733

Documentation

EHNA, Hydrochloride - CAS 51350-19-7 - Calbiochem MSDS

职位

物料安全数据表 (MSDS) 

EHNA, Hydrochloride - CAS 51350-19-7 - Calbiochem 分析证书

标题批号
324630

参考

参考信息概述
Burton, P., et al. 2010. Biochem. J. in press.
Lorbar, M., et al. 1999. J. Mol. Cell. Cardiol. 31, 401.
Verde, I., et al. 1999. Br. J. Pharmacol. 127, 65.
Reynolds, A.J., et al. 1996. Brain Res. 798, 67.
Mery, P.F., et al. 1995. Mol. Pharmacol. 48, 121.
Podzuweit, T., et al. 1995. Cell. Signal. 7, 733.
Bessodes, M., et al. 1982. Biochem. Pharmacol. 31, 879.
Bouchard, P., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 1033.
数据表

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision09-February-2012 RFH
Synonymserythro-9-(2-Hydroxy-3-nonyl)adenine, HCl
DescriptionThe racemic mixture of a cell-permeable adenine derivative that acts as a PDE II-selective phosphodiesterase inhibitor (IC50 = 0.8 and 2 µM against human and procine PDE II, respectively) and adenosine deaminase (Ki = 4 nM), while exhibiting little or much reduced potency toward PDE I/II/IV isozymes (IC50 >100 µM) of both human and porcine species. EHNA at 10 µM concentration is also reported to effectively and reversibly block the differentiation and maintain the pluripotency of hES (human embryonic stem) cell line SA121 in feeder-free cultures without exogenously added FGF for up to 30 passages in a manner independent of its known ADA and PDE inhibitory activities.
FormWhite solid
CAS number51350-19-7
Chemical formulaC₁₄H₂₃N₅O · HCl
Structure formulaStructure formula
Purity≥97% by HPLC
SolubilityH₂O (25 mg/ml)
Storage +2°C to +8°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesBurton, P., et al. 2010. Biochem. J. in press.
Lorbar, M., et al. 1999. J. Mol. Cell. Cardiol. 31, 401.
Verde, I., et al. 1999. Br. J. Pharmacol. 127, 65.
Reynolds, A.J., et al. 1996. Brain Res. 798, 67.
Mery, P.F., et al. 1995. Mol. Pharmacol. 48, 121.
Podzuweit, T., et al. 1995. Cell. Signal. 7, 733.
Bessodes, M., et al. 1982. Biochem. Pharmacol. 31, 879.
Bouchard, P., et al. 1981. Proc. Natl. Acad. Sci. USA 78, 1033.